John Lee

2018 - PhaseBio Pharmaceuticals

In 2018, John Lee earned a total compensation of $501.1K as Chief Medical Officer at PhaseBio Pharmaceuticals, a 35% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$146,400
Option Awards$27,626
Salary$326,337
Other$690
Total$501,053

Lee received $326.3K in salary, accounting for 65% of the total pay in 2018.

Lee also received $146.4K in non-equity incentive plan, $27.6K in option awards and $690 in other compensation.

Rankings

In 2018, John Lee's compensation ranked 11,869th out of 14,244 executives tracked by ExecPay. In other words, Lee earned more than 16.7% of executives.

ClassificationRankingPercentile
All
11,869
out of 14,244
17th
Division
Manufacturing
4,807
out of 5,765
17th
Major group
Chemicals And Allied Products
1,821
out of 2,128
14th
Industry group
Drugs
1,554
out of 1,817
15th
Industry
Pharmaceutical Preparations
1,192
out of 1,391
14th
Source: SEC filing on April 5, 2019.

Lee's colleagues

We found three more compensation records of executives who worked with John Lee at PhaseBio Pharmaceuticals in 2018.

2018

Jonathan Mow

PhaseBio Pharmaceuticals

Chief Executive Officer

2018

John Sharp

PhaseBio Pharmaceuticals

Chief Financial Officer

2018

John Sharp

PhaseBio Pharmaceuticals

Chief Financial Officer

News

You may also like